$FTLF

FITLIFE BRANDS, INC. (FTLF): Results of Operations and Financial Condition

FITLIFE BRANDS, INC. (FTLF) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_1004382.htm EXHIBIT 99.1 ex_1004382.htm Exhibit 99.1 FitLife Brands Announces Second Quarter 2026 Results OMAHA, NE – August 13, 2026 – FitLife Brands, Inc. (“ FitLife ” or the “ Company ”) (NASDAQ: FTLF), a provider of innovative and proprietary nutritional suppleme

Original reporting
Published Aug 13, 2026, 12:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 12:32 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$FTLF
Neutral
medium confidence
Mentioned
$FTLF
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$FTLFNeutralMed
01

Why it matters

Revenue growth is strong and net income increased, but profitability deteriorated at the gross margin level and Legacy revenue fell due to lower sales to a large specialty retail partner (primarily GNC) and online weakness tied to MRC.

02

Market read

This is a fresh quarterly earnings disclosure with acquisition-driven growth and explicit margin and partner-driven headwinds, which can shift near-term valuation expectations.

03

What to watch

Gross margin decline is attributed to Irwin’s historically lower margin, so traders should separate acquisition mix effects from underlying Legacy gross margin and contribution trends.

Relevance 7/10Novelty 7/10Timing: pre-market today (SEC 8-K filed Aug 13, 2026)

Background

FitLife’s Q2 2026 8-K reports results of operations and financial condition, including performance of acquired Irwin Naturals versus Legacy FitLife brands.

Company-level read

Ticker impact

$FTLFNeutralMedium confidence
Context

FitLife reported Q2 2026 results with revenue up 65% to $26.5M, driven by the Irwin Naturals acquisition, plus margin compression to 37.0%.

Expected impact

Near-term trading likely hinges on whether investors view margin compression and Legacy declines as temporary post-acquisition effects versus structural weakness.

Evidence & confidence

The filing provides concrete quarterly datapoints (revenue, net income, EPS, gross margin, segment mix, and partner-driven declines) that can reframe expectations for the post-merger run-rate and profitability trajectory.

Market effects

Nutritional supplement peers may face read-through on acquisition-led growth versus margin pressure and retail-partner concentration risk.

Limited, company-specific impact centered on FitLife’s Omaha-based operations and US retail channels.

Low, primarily US-focused consumer wellness and wholesale/online mix dynamics.

Counterpoint

The headline growth may be largely acquisition math, while Legacy FitLife weakness tied to a major specialty retail partner could persist and cap multiple expansion.

Key entities

  • FitLife Brands, Inc.

    NASDAQ-listed nutritional supplements and wellness products company reporting Q2 2026 results in an SEC 8-K.

  • Irwin Naturals

    Acquired Aug 8, 2025, contributing $10.7M of wholesale revenue in Q2 2026 and driving lower gross margin versus Legacy.

  • GNC

    Specialty retail partner cited as a driver of Legacy FitLife wholesale decline in Q2 2026.

Related articles

$CPKMedAI 8/10

Chesapeake Utilities (CPK) Q2 2026 Earnings Call Transcript

Chesapeake Utilities (CPK) reported Q2 2026 adjusted net income of $25.4 million, up 5% year over year, and adjusted EPS of $1.05. Management raised 2026 capital guidance to $550 million to $600 million and expects 2028 EPS of $7.75 to $8.00. It also discussed the $1.2 billion Florida Energy Pathway project and reaffirmed efficiency and dividend plans.

$QNSTHighAI 9/10

QuinStreet (QNST) Q4 2026 Earnings Call Transcript

QuinStreet (QNST) reported Q4 FY2026 revenue of $373.9M, up 43% y/y, and full-year revenue of $1.3B, up 18% y/y, driven by Financial Services and Home Services. Adjusted EBITDA rose to $41.4M (11.1% margin). Non-GAAP EPS was $0.50 in Q4. Q1 2027 revenue guidance is $370M-$380M.

$AVPTMedAI 9/10

AvePoint (AVPT) Q2 2026 Earnings Call Transcript

AvePoint (AVPT) reported Q2 2026 revenue of $124.5M, up 22% YoY, with SaaS revenue $98.5M (79% of total). Total ARR was $465.1M (+27%), net new ARR $29.9M, and GAAP operating margin 8.2%. Full-year guidance: ARR $522.1M-$528.1M and revenue $508.5M-$512.5M. The company also spent $50M on share repurchases in Q2.

$NUTXMedAI 8/10

Nutex Health (NUTX) Q2 2026 Earnings Call Transcript

Nutex Health (NUTX) reported Q2 2026 results on an earnings call. Total revenue fell to $210.8M from $244.0M. Net income rose to $65.8M, diluted EPS to $9.38, and adjusted EBITDA to $90.0M. Management cited lower contract services costs from a HaloMD amendment and higher patient visits, plus a hospital expansion pipeline.

$ALRMMedAI 9/10

Alarm.com (ALRM) Q2 2026 Earnings Call Transcript

Alarm.com (ALRM) reported Q2 2026 results. SaaS and license revenue was $188.8 million, up 11.1% YoY and above guidance midpoint. Total revenue rose 9.2% to $277.7 million. Non-GAAP adjusted EBITDA was $57.7 million, up 15.7%, and adjusted EPS was $0.77. Full-year guidance was raised for SaaS, total revenue, and adjusted EBITDA.

$INTCMedAI 8/10

A $20 Billion Reason Why Intel Stock Is in Focus

Intel expects Q3 revenue of $15.8B to $16.8B versus about $15.1B consensus, and adjusted EPS of $0.38 versus $0.27 consensus. Intel raised 2026 capital spending to over $20B and plans more in 2027. It is investing in Ireland foundry operations and signed 10 server CPU customer agreements. Analysts are mixed on INTC targets.